Home・Listă Acțiuni・Hims & Hers Health Inc

Hims & Hers Health Inc

Deschisă

SectorConsumator defensiv

32.07 4.09

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

30.24

Maxim

31.73

Indicatori cheie
By Trading Economics
Venit	-113M -92M
Vânzări	-9.7M 608M
P/E Medie Sector	57.137 33.699
EPS	-0.19
Marjă de profit	-15.148
Angajați	2,442
EBITDA	-107M -80M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	-3.05% downside

Dividende
By Acuity
Următoarele câștiguri	10 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	266M 7B
Deschiderea anterioară	27.98
Închiderea anterioară	32.07

Sentimentul știrilor

By Acuity

50%

52 / 130 Clasament în Consumer defensive

Hims & Hers Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 aug. 2026, 23:41 UTC

News

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

31 iul. 2026, 19:36 UTC

Social Media

News

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

30 iul. 2026, 20:11 UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

29 iul. 2026, 23:16 UTC

Social Media

News

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

28 iul. 2026, 23:41 UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

27 iul. 2026, 20:03 UTC

News

Social Media

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

24 iul. 2026, 23:16 UTC

Social Media

Hims & Hers Health Inc. shares rose after-hours following positive votes from an FDA/HHS panel on six peptides, with a final decision expected in up to 12 months.

23 iul. 2026, 23:26 UTC

News

Hims & Hers Health Inc shares are higher after an FDA advisory panel recommended easing restrictions on a popular peptide and Canaccord reiterated a Buy rating.

22 iul. 2026, 23:16 UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

21 iul. 2026, 17:31 UTC

News

Hims & Hers Health Inc shares are declining amid an investigation into potential wrongdoing and concerns over FDA approval of key peptides.

20 iul. 2026, 18:37 UTC

News

Hims & Hers Health Inc. is trading higher amid broader market dynamics, despite earlier pulling back from a session high.

Comparație

Modificare preț

Hims & Hers Health Inc Așteptări

Obiectiv de preț

By TipRanks

-3.05% jos

Prognoză pe 12 luni

Medie 29.88 USD -3.05%

Maxim 40 USD

Minim 21 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHims & Hers Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 13 analiști care au acordat evaluări ale acțiunilor Hims & Hers Health Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

52 / 130 Clasament în Consumator defensiv

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.